Copley Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Sell
4,149
-1,719
-29% -$139K 0.2% 71
2026
Q1
$508K Sell
5,868
-428
-7% -$41K 0.31% 47
2025
Q4
$605K Sell
6,296
-358
-5% -$34.8K 0.37% 36
2025
Q3
$634K Sell
6,654
-311
-4% -$28.6K 0.43% 35
2025
Q2
$607K Sell
6,965
-822
-11% -$69.7K 0.45% 36
2025
Q1
$700K Sell
7,787
-123
-2% -$11K 0.54% 31
2024
Q4
$632K Buy
7,910
+204
+3% +$17.7K 0.48% 35
2024
Q3
$694K Buy
+7,706
New +$648K 0.63% 24

Other funds holding MDT

Copley Financial Group's MDT Position: Q2 2026 in Review

Copley Financial Group reduced its Medtronic (MDT) stake by 29% in Q2 2026, selling an estimated $139K and leaving 4,149 shares worth $325K. The position accounts for 0.2% of the portfolio, ranked #71.

Copley Financial Group first reported a position in MDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $700K in Q1 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Copley Financial Group held 4,149 shares of Medtronic worth $325K as of Q2 2026.
  • Copley Financial Group sold 1,719 Medtronic shares in Q2 2026, an estimated $139K.
  • Medtronic made up 0.2% of Copley Financial Group's portfolio in Q2 2026, its #71 holding.
  • Copley Financial Group first reported a position in Medtronic in Q3 2024 and has held it in 8 quarters since.
  • Copley Financial Group's Medtronic position peaked at $700K in Q1 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Copley Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.